Alterity Therapeutics (ATHE) Exchange Rate Effect (2016 - 2020)
Alterity Therapeutics (ATHE) posted quarterly Exchange Rate Effect of -$172360.6 for Q2 2020, up 39.07% year-over-year from -$123933.5 in Q3 2019, and down 297.37% quarter-over-quarter from $87328.6 in Q4 2019.
Alterity Therapeutics (ATHE) Exchange Rate Effect (2016 - 2020) Analysis & Trends
Alterity Therapeutics' Exchange Rate Effect history runs 5 years deep, the most recent figure standing at -$172360.6 for Q2 2020.
- In Q2 2020, Exchange Rate Effect rose 39.07% year-over-year to -$172360.6; the TTM figure through Jun 2020 stood at -$203082.4 (up 65.29% YoY), while the FY2025 annual figure was -$127045.9, down 174.04% from the prior year.
- Exchange Rate Effect for Q2 2020 stood at -$172360.6, down from $87328.6 in the prior quarter.
- The five-year high for Exchange Rate Effect was $409359.2 in Q4 2016, with the low at -$709904.9 in Q2 2016.
- The 5-year median for Exchange Rate Effect is -$85127.6 (2018), against an average of -$121323.2.
- The sharpest annual moves came in 2018 and 2019: Exchange Rate Effect jumped 135.15% in 2018, then tumbled 13536.85% in 2019.
- Alterity Therapeutics' Exchange Rate Effect stood at $409359.2 in 2016, then plunged by 214.58% to -$469062.8 in 2017, then surged by 135.15% to $164855.6 in 2018, then tumbled by 47.03% to $87328.6 in 2019, then sank by 297.37% to -$172360.6 in 2020.
- Business Quant data shows ATHE's Exchange Rate Effect at -$172360.6 in Q2 2020, $87328.6 in Q4 2019, and -$282906.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | - |
| 10 | Alterity Therapeutics | 48.83 Mn | 16.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -172,360.55 |
| Jun 30, 2020 | -172,360.55 |
| Dec 31, 2019 | 87,328.62 |
| Dec 31, 2019 | 87,328.62 |
| Jun 30, 2019 | -282,906.04 |
| Jun 30, 2019 | -282,906.04 |
| Dec 31, 2018 | 164,855.57 |
| Dec 31, 2018 | 164,855.57 |
| Jun 30, 2018 | 2,105.45 |
| Jun 30, 2018 | 2,105.45 |
| Dec 31, 2017 | -469,062.76 |
| Dec 31, 2017 | -469,062.76 |
| Dec 31, 2016 | 409,359.19 |
| Dec 31, 2016 | 409,359.19 |
| Jun 30, 2016 | -709,904.92 |
| Jun 30, 2016 | -709,904.92 |